Segment disclosures

Company overview

소마젠

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 23 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-318755533 USD20260515Open filing evidence
2025-01-01 – 2025-12-3141619339 USD20260323Open filing evidence
2025-07-01 – 2025-09-3010893833 USD20251114Open filing evidence
2025-01-01 – 2025-09-3029826287 USD20251114Open filing evidence
2025-04-01 – 2025-06-3011141158 USD20250814Open filing evidence
2025-01-01 – 2025-06-3018932454 USD20250814Open filing evidence
2025-01-01 – 2025-03-317791296 USD20260515Open filing evidence
2024-01-01 – 2024-12-3132012115 USD20260323Open filing evidence
2024-07-01 – 2024-09-308672946 USD20251114Open filing evidence
2024-01-01 – 2024-09-3022044515 USD20251114Open filing evidence
2024-04-01 – 2024-06-306325612 USD20250814Open filing evidence
2024-01-01 – 2024-06-3013371569 USD20250814Open filing evidence
2024-01-01 – 2024-03-317045957 USD20250515Open filing evidence
2023-01-01 – 2023-12-3124723776 USD20260323Open filing evidence
2023-07-01 – 2023-09-305872907 USD20241114Open filing evidence
2023-01-01 – 2023-09-3018421733 USD20241114Open filing evidence
2023-04-01 – 2023-06-306026035 USD20240814Open filing evidence
2023-01-01 – 2023-06-3012548826 USD20240814Open filing evidence
2023-01-01 – 2023-03-316522791 USD20240516Open filing evidence
2022-01-01 – 2022-12-3133572854 USD20250321Open filing evidence
2022-07-01 – 2022-09-309776843 USD20231114Open filing evidence
2022-01-01 – 2022-09-3025305388 USD20231114Open filing evidence
2021-01-01 – 2021-12-3124983530 USD20240321Open filing evidence